Funding for this research was provided by:
National Institutes of Health (F32GM133127, R01GM127489, DP5-OD021344)
Defense Advanced Research Projects Agency (HR0011-17-2-0043)
Joint Programming Initiative on Antimicrobial Resistance (7044-00004B)
Received: 6 August 2019
Accepted: 5 February 2020
First Online: 16 March 2020
: J.B.-D. is a scientific advisory board member of SNIPR Biome and Excision Biotherapeutics and a scientific advisory board member and co-founder of Acrigen Biosciences. J.B.-D. and N.D.M. have filed patents on technology related to anti-CRISPR proteins. R.P.R. is a consultant for Ancilia Inc.